{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:39:41Z","timestamp":1760243981822,"version":"build-2065373602"},"reference-count":95,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology Nursing"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.soncn.2025.151914","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:20:02Z","timestamp":1757589602000},"page":"151914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Inequalities in Treatment for Prostate Cancer Affecting Demand for Secondary and Tertiary Services: Secondary Analysis of Linked National Datasets"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0810-8927","authenticated-orcid":false,"given":"Ashleigh Lauren","family":"Ward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Cruickshank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liz","family":"Forbat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.soncn.2025.151914_bib0001","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.soncn.2025.151914_bib0002","first-page":"391","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.soncn.2025.151914_bib0003","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejca.2020.01.011","article-title":"The cost of cancer in Europe in 2018","volume":"129","author":"Hofmarcher","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.soncn.2025.151914_bib0004","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","article-title":"Planning for tomorrow: Global cancer incidence and the role of prevention 2020-2070","volume":"18","author":"Soerjomataram","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"year":"2024","series-title":"Europe\u2019s Beating Cancer Plan: Communication from the Commission to the European Parliament and the Council","key":"10.1016\/j.soncn.2025.151914_bib0005"},{"year":"2015","series-title":"Delivering Affordable Cancer Care: A Value Challenge to Health Systems","author":"Thomas","key":"10.1016\/j.soncn.2025.151914_bib0006"},{"key":"10.1016\/j.soncn.2025.151914_bib0007","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.2217\/fon-2021-0341","article-title":"Navigating the high costs of cancer care: opportunities for patient engagement","volume":"17","author":"Gunn","year":"2021","journal-title":"Fut Oncol"},{"key":"10.1016\/j.soncn.2025.151914_bib0008","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jnci\/djq495","article-title":"Projections of the cost of cancer care in the United States: 2010\u20132020","volume":"103","author":"Mariotto","year":"2011","journal-title":"J Natl Cancer Inst"},{"year":"2011","series-title":"Cancer Diagnosis and Treatment: A 2021 Projection","key":"10.1016\/j.soncn.2025.151914_bib0009"},{"year":"2008","series-title":"Projection of Australian Health Expenditure by Disease, 2003 to 2033","author":"Goss","key":"10.1016\/j.soncn.2025.151914_bib0010"},{"key":"10.1016\/j.soncn.2025.151914_bib0011","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S2214-109X(18)30411-X","article-title":"Effect on longevity of one-third reduction in premature mortality from non-communicable diseases by 2030: a global analysis of the Sustainable Development Goal health target","volume":"6","author":"Cao","year":"2018","journal-title":"Lancet Global Health"},{"year":"2024","series-title":"Cancer Tomorrow: Predictions of the Future Cancer Incidence and Mortality Burden Worldwide Up Until 2050","key":"10.1016\/j.soncn.2025.151914_bib0012"},{"key":"10.1016\/j.soncn.2025.151914_bib0013","article-title":"Innovation to advance cancer control equitably","volume":"8","author":"Kutluk","year":"2022","journal-title":"JCO Global Oncol"},{"year":"2013","series-title":"Spending on Health and Social Care over the Next 50 Years: Why Think Long Term?","author":"Appleby","key":"10.1016\/j.soncn.2025.151914_bib0014"},{"key":"10.1016\/j.soncn.2025.151914_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcpo.2023.100420","article-title":"Five changes needed to Scottish cancer policy to support necessary transformation of services","volume":"36","author":"Ward","year":"2023","journal-title":"J Cancer Policy"},{"key":"10.1016\/j.soncn.2025.151914_bib0016","first-page":"3","article-title":"Features that hindered the development of a national prostate cancer service","author":"Ward","year":"2023","journal-title":"Front Health Serv"},{"year":"2024","series-title":"Cancer Incidence in Scotland to December 2022","key":"10.1016\/j.soncn.2025.151914_bib0017"},{"key":"10.1016\/j.soncn.2025.151914_bib0018","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","article-title":"Global cancer transitions according to the Human Development Index (2008-2030): a population-based study","volume":"13","author":"Bray","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.soncn.2025.151914_bib0019","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN. 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"year":"2018","series-title":"Scottish Prostate Cancer Statistics","author":"Deas","key":"10.1016\/j.soncn.2025.151914_bib0020"},{"year":"2024","series-title":"Prostate cancer: Full guideline","key":"10.1016\/j.soncn.2025.151914_bib0021"},{"year":"2019","series-title":"Population Estimates by Urban Rural Classification (2011 Data Zone Based)","key":"10.1016\/j.soncn.2025.151914_bib0022"},{"key":"10.1016\/j.soncn.2025.151914_bib0023","doi-asserted-by":"crossref","first-page":"205","DOI":"10.13031\/2013.18187","article-title":"Rural health care in the U.K.: a rapidly changing scene","volume":"11","author":"Godden","year":"2005","journal-title":"J Agri Safety Health"},{"key":"10.1016\/j.soncn.2025.151914_bib0024","first-page":"4","article-title":"Spatial inequalities in life expectancy within postindustrial regions of Europe: a cross-sectional observational study","author":"Taulbut","year":"2014","journal-title":"Br Med J"},{"year":"2011","series-title":"UK Cancer Atlas","key":"10.1016\/j.soncn.2025.151914_bib0025"},{"key":"10.1016\/j.soncn.2025.151914_bib0026","article-title":"The worldwide epidemiology of prostate cancer: perspectives from autopsy studies","volume":"15","author":"Haas","year":"2008","journal-title":"Can J Urol"},{"key":"10.1016\/j.soncn.2025.151914_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.29538","article-title":"Prevalence of incidental prostate cancer: a systematic review of autopsy studies","volume":"137","author":"Bell","year":"2015","journal-title":"Int J Cancer"},{"year":"2007","series-title":"Comparisons of Health Related Measures between Glasgow and the Rest of Scotland","author":"Gray","key":"10.1016\/j.soncn.2025.151914_bib0028"},{"key":"10.1016\/j.soncn.2025.151914_bib0029","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.pmedr.2016.08.004","article-title":"Unravelling the Glasgow effect: the relationship between accumulative bio-psychosocial stress, stress reactivity and Scotland\u2019s health problems","volume":"4","author":"Cowley","year":"2016","journal-title":"Prev Med Rep"},{"year":"2013","series-title":"Everyone Matters: 2020 Workforce Vision","key":"10.1016\/j.soncn.2025.151914_bib0030"},{"year":"2019","series-title":"Cancer waiting times","author":"NHS National Services Scotland","key":"10.1016\/j.soncn.2025.151914_bib0031"},{"year":"2000","series-title":"Our National Health: A Plan for Action, a Plan for Change","key":"10.1016\/j.soncn.2025.151914_bib0032"},{"year":"2008","series-title":"Better Cancer Care: An Action Plan","key":"10.1016\/j.soncn.2025.151914_bib0033"},{"year":"2024","series-title":"Cancer Waiting Times 1 July to 30 September 2024","key":"10.1016\/j.soncn.2025.151914_bib0034"},{"year":"2018","series-title":"Prostate Cancer: Scottish Data","key":"10.1016\/j.soncn.2025.151914_bib0035"},{"year":"2021","series-title":"Prostate Cancer: Diagnosis and Management (NG131)","key":"10.1016\/j.soncn.2025.151914_bib0036"},{"year":"2018","series-title":"Waiting Times: Improvement Plan","key":"10.1016\/j.soncn.2025.151914_bib0037"},{"year":"2004","series-title":"Territorial Politics and Health Policy","author":"Greer","key":"10.1016\/j.soncn.2025.151914_bib0038"},{"year":"2010","series-title":"Delivering Health Care through Managed Clinical Networks (MCNs): Lessons from the North","author":"Guthrie","key":"10.1016\/j.soncn.2025.151914_bib0039"},{"year":"1997","series-title":"Designed to Care: Renewing the National Health Service in Scotland","key":"10.1016\/j.soncn.2025.151914_bib0040"},{"year":"2001","series-title":"71 Cancer in Scotland: Action for Change: Regional Cancer Advisory Groups (RCAGs)","key":"10.1016\/j.soncn.2025.151914_bib0041"},{"year":"2007","series-title":"21 Strengthening the Role of Managed Clinical Networks","key":"10.1016\/j.soncn.2025.151914_bib0042"},{"year":"2016","series-title":"Beating Cancer: Ambition and Action","key":"10.1016\/j.soncn.2025.151914_bib0043"},{"year":"2016","series-title":"Fundamentals of Descriptive Statistics","author":"Holcomb","key":"10.1016\/j.soncn.2025.151914_bib0044"},{"year":"2024","series-title":"Cancer Waiting Times 1 July to 30 September 2024","key":"10.1016\/j.soncn.2025.151914_bib0045"},{"year":"2006","series-title":"Cancer in Scotland: Radiotherapy Activity Planning","key":"10.1016\/j.soncn.2025.151914_bib0046"},{"year":"2010","series-title":"Projections of Cancer Incidence in Scotland to 2020","author":"Oduro","key":"10.1016\/j.soncn.2025.151914_bib0047"},{"year":"2018","series-title":"Prostate Cancer: Scottish Data","key":"10.1016\/j.soncn.2025.151914_bib0048"},{"year":"2016","series-title":"Prostate Cancer Risk Management Programme: Overview","key":"10.1016\/j.soncn.2025.151914_bib0049"},{"key":"10.1016\/j.soncn.2025.151914_bib0050","doi-asserted-by":"crossref","unstructured":"Bordersen J, Schwartz LM, Heneghan C, et al. Overdiagnosis: what is it and what isn\u2019t it? Br Med J. 23.","DOI":"10.1136\/ebmed-2017-110886"},{"key":"10.1016\/j.soncn.2025.151914_bib0051","first-page":"37","article-title":"10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.soncn.2025.151914_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2018.10.032","article-title":"Comparative effectiveness of radical prostatectomy versus external bean radiation therapy plus brachytherapy in patients with high-risk localised prostate cancer","volume":"75","author":"Berg","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.soncn.2025.151914_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(12)70560-0","article-title":"Androgen deprivation therapy alone or with docetaxel in non-castrate resistant metastatic prostate cancer: A randomised, open label, phase 3 trial","volume":"14","author":"Gravis","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.soncn.2025.151914_bib0054","article-title":"The development of intermediate clinical endpoints in cancer of the prostate","volume":"107","author":"Sweeney","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.soncn.2025.151914_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)01037-5","article-title":"Addition of docetaxel, zolendronic acid, or both to first-line long-term hormone therapy in prostate cancer: survival results from an adaptive, multiarm, multistage, platform randomised control trial","volume":"387","author":"James","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.soncn.2025.151914_bib0056","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdy072","article-title":"Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol","volume":"29","author":"Sydes","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soncn.2025.151914_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2017.10.002","article-title":"Comparison of abiraterone acetate and docetaxel with androgen deprivation therapy in high risk and metastatic hormone-na\u00efve prostate cancer: a systematic review and network meta-analysis","volume":"73","author":"Wallis","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.soncn.2025.151914_bib0058","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdy071","article-title":"What is the optimal systematic treatment of men with metastatic, hormone-na\u00efve prostate cancer? A STOPCAP systematic review and network meta-analysis","volume":"29","author":"Vale","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soncn.2025.151914_bib0059","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/2051415813512303","article-title":"Prostate cancer in Scotland: does geography matter? An analysis of incidence, disease characteristics and survival between urban and rural areas","volume":"7","author":"Laing","year":"2013","journal-title":"J Clin Urol"},{"key":"10.1016\/j.soncn.2025.151914_bib0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-042606","article-title":"Prescribing patterns for medical treatment of suspected prostatic obstruction: a longitudinal register-based study of the Scottish Health and Social Care Open Data","volume":"11","author":"Andreis","year":"2021","journal-title":"BMJ Open"},{"year":"2021","series-title":"SEER Cancer Statistics Review, 1975-2018","author":"Howlader","key":"10.1016\/j.soncn.2025.151914_bib0061"},{"key":"10.1016\/j.soncn.2025.151914_bib0062","first-page":"209","article-title":"Global Cancer Statistics. 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.soncn.2025.151914_bib0063","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/annonc\/mdw027","article-title":"The global decrease in cancer mortality: trends and disparities","volume":"27","author":"Hashim","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soncn.2025.151914_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(18)30415-7","article-title":"Integration of oncology and palliative care: a Lancet Oncology Commission","volume":"19","author":"Kaasa","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.soncn.2025.151914_bib0065","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmjspcare-2012-000415","article-title":"Defining the illness trajectory of metastatic breast cancer","volume":"5","author":"Reed","year":"2015","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.soncn.2025.151914_bib0066","article-title":"Functional trajectories and resilience among adults with advanced lung cancer","volume":"3","author":"Presley","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.soncn.2025.151914_bib0067","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ijc.33744","article-title":"Pan-cancer analysis of prognostic metastatic phenotypes","volume":"150","author":"Zaorsky","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.soncn.2025.151914_bib0068","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s11764-021-01024-8","article-title":"Living with and beyond metastatic non-small cell lung cancer: the survivorship experience for people treated with immunotherapy or targeted therapy","volume":"15","author":"Lai-Kwon","year":"2021","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.soncn.2025.151914_bib0069","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s11764-019-00770-0","article-title":"The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors","volume":"13","author":"Lai-Kwon","year":"2019","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.soncn.2025.151914_bib0070","first-page":"561","article-title":"An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors","volume":"28","author":"O'Reilly","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.soncn.2025.151914_bib0071","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000260","article-title":"Quality of life in long-term survivors of advanced melanoma treated with checkpoint inhibitors","volume":"8","author":"Mamoor","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.soncn.2025.151914_bib0072","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41571-022-00600-w","article-title":"Immune-checkpoint inhibitors: long-term implications of toxicity","volume":"19","author":"Johnson","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.soncn.2025.151914_bib0073","doi-asserted-by":"crossref","DOI":"10.1097\/NCC.0000000000000683","article-title":"Exploring the experiences of people treated with immunotherapies for advanced melanoma and those caring for them: \"real-World\" data","volume":"43","author":"Milne","year":"2020","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.soncn.2025.151914_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.soncn.2025.151914_bib0075","article-title":"Living in the twilight zone: a qualitative study on the experiences of patients with advanced cancer obtaining long-term response to immunotherapy or targeted therapy","author":"Zwanenburg","year":"2022","journal-title":"J Cancer Surviv"},{"key":"10.1016\/j.soncn.2025.151914_bib0076","first-page":"1845","article-title":"Certainty within uncertainty: a qualitative study of the experience of metastatic melanoma patients undergoing pembrolizumab immunotherapy","volume":"27","author":"Levy","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.soncn.2025.151914_bib0077","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(18)30415-7","article-title":"Integration of oncology and palliative care: a Lancet Oncology Commission","volume":"19","author":"Kaasa","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.soncn.2025.151914_bib0078","article-title":"Living with advanced cancer and the role of the primary care provider: the missing piece in the survivorship discourse","volume":"26","author":"Nekhlyudov","year":"2017","journal-title":"Eur J Cancer Care Engl"},{"key":"10.1016\/j.soncn.2025.151914_bib0079","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.22.02212","article-title":"Evolving landscape of metastatic cancer survivorship: reconsidering clinical care, policy, and research priorities for the modern era","volume":"41","author":"Lai-Kwon","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2025.151914_bib0080","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/oxfordjournals.pubmed.a024670","article-title":"Routinely collected data in national and regional databases \u2013 an under-used resource","volume":"19","author":"Bain","year":"1997","journal-title":"J Public Health"},{"year":"2011","series-title":"Cancer Atlas of the United Kingdom and Ireland","key":"10.1016\/j.soncn.2025.151914_bib0081"},{"key":"10.1016\/j.soncn.2025.151914_bib0082","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/jnnp.61.2.143","article-title":"Incidence of intracranial tumours in the Lothian region of Scotland, 1989-90","volume":"61","author":"Counsell","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.soncn.2025.151914_bib0083","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2133.1997.19482048.x","article-title":"An audit of the completeness of non-melanoma skin cancer registration in Greater Glasgow","volume":"137","author":"Lucke","year":"1997","journal-title":"Br J Dermatol"},{"year":"2019","series-title":"2018 Data Completeness","key":"10.1016\/j.soncn.2025.151914_bib0084"},{"key":"10.1016\/j.soncn.2025.151914_bib0085","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/bjc.1994.428","article-title":"How accurate are Scottish cancer registration data?","volume":"70","author":"Brewster","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.soncn.2025.151914_bib0086","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0033-3506(95)80206-1","article-title":"Registration of colorectal cancer in Scotland: an assessment of data accuracy based on review of medical records","volume":"109","author":"Brewster","year":"1995","journal-title":"Public Health"},{"key":"10.1016\/j.soncn.2025.151914_bib0087","first-page":"132","article-title":"Cancer research campaign health education programme to promote the early detection of cutaneous malignant melanoma, II: characteristics and incidence of melanoma","author":"Melia","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.soncn.2025.151914_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejon.2023.102271","article-title":"The future of cancer nursing in Europe: addressing professional issues in education, research, policy and practice","author":"Drury","year":"2023","journal-title":"Eur J Oncol Nursing"},{"key":"10.1016\/j.soncn.2025.151914_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2024.151627","article-title":"Advanced practice nursing titles and roles in cancer care: a scoping review","volume":"40","author":"Dowling","year":"2024","journal-title":"Semin Oncol Nursing"},{"key":"10.1016\/j.soncn.2025.151914_bib0090","unstructured":"Ward AL. Understanding capacity development needs within the NHS Scotland prostate cancer service: a Delphi study. 2020. Thesis."},{"key":"10.1016\/j.soncn.2025.151914_bib0091","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.nedt.2004.07.012","article-title":"Evaluation of a mentorship programme for specialist practitioners","volume":"24","author":"Rosser","year":"2004","journal-title":"Nurse Educ Today"},{"key":"10.1016\/j.soncn.2025.151914_bib0092","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1258\/135581904322724112","article-title":"Changing the skill-mix of the health care workforce","volume":"9","author":"Sibbald","year":"2004","journal-title":"J Health Serv Res Policy"},{"key":"10.1016\/j.soncn.2025.151914_bib0093","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.ijnurstu.2009.03.006","article-title":"Working patterns and perceived contribution of prostate cancer clinical nurse specialists: a mixed method investigation","volume":"46","author":"Ream","year":"2009","journal-title":"Int J Nursing Stud"},{"key":"10.1016\/j.soncn.2025.151914_bib0094","article-title":"The specialist nursing workforce caring for men with prostate cancer in the UK","volume":"10","author":"Leary","year":"2016","journal-title":"Int J Urol Nursing"},{"key":"10.1016\/j.soncn.2025.151914_bib0095","first-page":"12","article-title":"Knowledge gaps in prostate cancer treatment between physicians and clinical nurse specialists","author":"Gledhill","year":"2017","journal-title":"Int J Urol Nursing"}],"container-title":["Seminars in Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074920812500107X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074920812500107X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:10:57Z","timestamp":1760220657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074920812500107X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":95,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S074920812500107X"],"URL":"https:\/\/doi.org\/10.1016\/j.soncn.2025.151914","relation":{},"ISSN":["0749-2081"],"issn-type":[{"type":"print","value":"0749-2081"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Inequalities in Treatment for Prostate Cancer Affecting Demand for Secondary and Tertiary Services: Secondary Analysis of Linked National Datasets","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soncn.2025.151914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151914"}}